Immunology Scientist III: Target Discovery Lead

Genentech; South San Francisco (CA); Sur place; USD 103 000 - 192 000; Plein temps

Avantages offerts par ce poste

Relocation benefits

Résumé du poste

Genentech's Immunology Department is seeking a Scientist 3 to investigate novel mechanisms and potential therapeutic targets to treat inflammatory diseases. You will lead projects advancing immune regulation research and contribute to early clinical development.

The role requires strong industry experience in target discovery, independence, and collaboration across labs. You will apply state-of-the-art techniques to test new pathways and determine MOA of targets, with relocation benefits

Qualifications

• PhD with publications in immunology or related field.
• Hands-on experience in cellular and molecular immunology, including primary cell isolation, in vitro assays, flow cytometry, in vivo models.
• Independent design/interpretation of experiments.
• Excellent communication and collaborative skills.
• Ability to present research at internal meetings.

Responsabilités

• Lead projects to investigate novel immunoregulatory mechanisms.
• Advance pipeline programs into early clinical development.
• Provide scientific and technical leadership across immunology labs.
• Generate solid proof-of-concept data to support target discovery.

Connaissances

Independent experimental design

Excellent communication

Collaborative mindset

Formation

PhD in immunology or related field

Outils

Flow cytometry

In vivo animal models

Genome editing (CRISPR)

Description du poste

Genentech's Immunology Department is seeking a Scientist 3 to investigate novel mechanisms and potential therapeutic targets to treat inflammatory diseases. You will lead projects advancing immune regulation research and contribute to early clinical development.

The role requires strong industry experience in target discovery, independence, and collaboration across labs. You will apply state-of-the-art techniques to test new pathways and determine MOA of targets, with relocation benefits